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The incidence of cancer has increased significantly 
over the past several years in the Asia-Pacific region. 
Cancer is one of the leading causes of death in South 
Korea, Taiwan, Singapore, Hong Kong as well as in 
urban China, and has become a major concern for many 
healthcare systems in the Asia-Pacific region [1]. This 
increase in cancer deaths has been attributed to the 
enormous economic successes in the East and Southeast 
Asia countries and China during the 1980s and 1990s, 
with impressive double-digit growth rates per year. Such 
economic successes have led to improved standards of 
living and healthcare systems resulting in fewer deaths 
from infectious diseases. For example, in the Seventh 
National Health Development Plan (1992-1996), the 
Thailand government had increased the health care 
budget by 54% in five years [1]. The increased wealth in 
the region has also allowed the private sectors to invest 
in healthcare services as demonstrated in Indonesia, and 
in Singapore with the restructuring and privatisation of 
its former public hospitals. The people in Asia are 
therefore living longer, expanding its population in a 
much more rapid rate compared to the population in 
Europe and the USA. In accordance with the statistics 
from the World Health Organization (WHO), the number 
of people worldwide who died from cancer in 2005 was 
7.6 million out of 58 million overall. More than 70% of 
cancer deaths have been in the low and middle income 
countries, attributed to the limited availability of 
healthcare resources to prevent, diagnose, and treat 
cancer. The projected number of cancer deaths will 
increase to 9 million in 2015 and 11.4 million in 2030 [2]. 
Aside from the rapid increase of the general 
population in the Asia-Pacific region compared to 
Europe and USA, the proportion of people who are 65 
years and older has been increasing at an even more 
alarming rate. For example, the population of China has 
increased by 31% over the last 25 years, while the 
number of people over 65 years has increased by 81%. 
By comparison, the population in UK has only risen by 
6% and the number of people older then 65 years by 7% 
in accordance with the Lancet Asia Medical Forum 
highlights of the “Asia and Cancer Management in the 
21
st Century” held in April 21-27, 2007 in Singapore [3]. 
These disparities are worrisome as cancers affect 
primarily people of older age. If the projection is correct, 
the number of cancer cases in Asia is set to increase from 
3.5 million in 2002 to 8.1 million by 2020 if the current 
management strategies are not changed. 
  The management of cancers in the Asia-Pacific 
region poses many challenges. In addition to enjoying 
longer lives, the people in the Asia-Pacific region are 
also adopting bad lifestyle habits that greatly increase the 
risk of cancer. About twice as many men in Asia smoke 
as compared to the men in Europe and to the USA where 
steps are taken to limit or prohibit smoking. Selective 
infections, such as the Helicobacter Pylori, exist in 75% 
of the population in South-Central Asia, which increases 
the risk of stomach cancer by 5-6 times. Hepatitis B virus 
is endemic, substantially increasing the risk of liver 
cancer in Southeast Asia. Nasopharyngeal cancer, often 
identified as “Hong Kong Cancer”, is a very common 
disease in Asia and predominantly affects people of 
southern Chinese descent. Research has been ongoing to 
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identify whether this disease is due to environmental 
factors, heredity, or otherwise. Exposure to sunlight also 
poses greater cancer risk. The global UV index for Asia 
is about twice that for the countries in the Northern 
Hemisphere. The economic growth has also led to rapid 
industrialisation and urbanisation, causing increased 
pollution which contributes to the increased risks in 
cancer, in particular for those types of cancers found in 
the West such as breast, lung, and prostate cancers. 
Lastly, a high-fat diet, drinking of alcohol, consumption 
of unhealthy food, and lack of physical exercise also 
increase cancer risk.  
The rapid increase in cancer in the Asia-Pacific 
countries places a huge burden on the Asia-Pacific 
society as a whole. The healthcare systems set up by the 
government of each country has to include the 
management of cancers. Most developing countries have 
opened clinics and specialty hospitals for cancer therapy. 
The cancer management programs also include 
prevention, diagnosis and treatment, in addition to the 
mechanism of payment for services such as health 
insurance. The cultural expectations from the public have 
to be addressed as well. Far fewer patients undergoing 
treatment are generally cured and this failure is often 
reflected as the failure of the oncologists.  
Cancer screening programs must be developed to 
detect early cancers to improve survival. Likewise there 
must be sufficient treatment facilities with appropriate 
experts and personnel to manage its cancer patients 
undergoing treatments in each country. While it has been 
presumed that different types of cancer predominate in 
different countries, the documentation of such patterns is 
still lacking. Likewise, the treatment preferences have 
been seen to vary from country to country or region to 
region. The presumed differences have been echoed by 
Dr. Franco Cavalli, President of the UICC who spoke at 
the Lancet Asia Medical Forum [3]. The president 
commented: “Speakers from outside Asia tend to 
overlook the huge differences which exist not only in 
terms of the causes of cancer, but also in terms of the 
management between the western countries and Asia. 
Conditions such as the structure of healthcare systems 
are very different from one country to the other. It is 
therefore necessary to adapt the discussion to local 
situations.” [4] 
Practising oncologists in each country of the Asia-
Pacific are invited to contribute an article (without 
restrictions - update, review or original work) on cancer 
care in their country to collectively compile a special 
issue in the Biomedical Imaging and Intervention Journal 
(biij). biij is an open access peer-reviewed online journal 
and the articles are available to the public, in particular 
healthcare providers, healthcare administrators, 
government officials, investors, patient advocates, and 
practising oncologists and associated staff. This special 
issue entitled “Frontiers of Cancer Care in Asia-Pacific 
Region” is intended to provide the oncologists in Asia-
Pacific the unique opportunity to present and hence, 
share their strategies of handling cancer patients in their 
individual country, in particular the attempts by the 
government and the private sectors to improve cancer 
care services, the philosophy of cancer care as well as the 
need for specialised staffing. Besides these invited 
articles, this special issue also contains articles of special 
interests: (1) translational research concept, (2) 
innovations of therapies, (3) informatics, (4) quality 
assurance processes, and (5) multi-discipline support 
from the medical physicists and nurses. These topics are 
chosen as complementary contributions to the articles by 
the oncologists from the Asia-Pacific. For example, 
research and participation in clinical trials in the Asia-
Pacific are still limited and will continue to increase [3]. 
The understanding with the basic knowledge of 
translational research concept and mechanisms certainly 
would be helpful in carrying out these research programs. 
The dedication of the authors from the Asia-Pacific 
countries deserves recognition for the successful 
compilation of this special issue of biij. First, the clinical 
practice of the oncologists in the Asian countries is 
generally very busy. The writing of these articles 
involves the sacrifice of personal time. The guest editors 
would like to thank the authors for investing a significant 
amount of their time and effort in writing these articles 
as well as allowing the manuscripts to undergo review. 
The second obstacle imposed on the authors is the 
translation of information into English. This is 
particularly difficult if English is not routinely used in 
their clinical practice. The third concern is the exposure 
of in-depth knowledge of the authors’ clinical practice. 
Because of these struggles and intimidating concerns, 
some oncologists have declined to contribute. For those 
who are willing to participate and share their experiences, 
this signifies their strong support for our vision to 
provide a common platform of presentations aimed at 
sharing knowledge with the unified goal of effective 
cancer care in the Asia-Pacific region. It is the hope of 
the guest editors that the articles in this special issue will 
contribute to the understanding of clinical practice for 
oncologists within as well as between the neighboring 
countries in the Asia-Pacific region to promote effective 
disease management with limited resources and/or 
infrastructure. The fruition of this special issue signifies 
our first call or attempt to address cancer care in the 
Asia-Pacific as a region and to discern similarities and 
differences. It is the hope of the guest editors that future 
calls will increase the participation of more oncology 
colleagues in the Asia-Pacific. Again, the guest editors 
would like to thank the authors and co-authors for 
making their contributions and the honorary editor (Dr. 
Kwan-Hoong Ng) for consenting to this special issue as 
part of the biij publication. 
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